A phase I/II study of olaparib in addition to cisplatin based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I/II

Latest Information Update: 12 Feb 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

11 May 2012 Trial phase changed from I to I/II as reported by as reported by United Kingdom Clinical Research Network record.
11 May 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by United Kingdom Clinical Research Network record.
15 Dec 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01491139).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com